Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Carnosine and Cognitive Training in Schizophrenia
NCT02686697Phase 3Completed
- Start
- Dec 2015
- Primary completion
- Jul 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing L-Carnosine + Cognitive Training with Placebo + Cognitive Training (2 arms). Primary endpoint: Cognitive Training Score at 8 weeks. Started Dec 2015; status: completed.
02
Drugs
carnosine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02686697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686697.